OSIR

Osiris Therapeutics, Inc. News Headlines

$10.49
*  
0.16
  negative  
1.5%
Get OSIR Alerts
*Delayed - data as of Jun. 19, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Osiris - Can Stem Cells Lead To Profits?
6/17/2013 4:04:00 PM - Seeking Alpha

Penny-Wise, Pound-Foolish Stem Cell Stocks
6/14/2013 9:48:00 AM - Seeking Alpha

Osiris Therapeutics To Present At Jefferies Global Conference;webcast At 4:00PM
6/3/2013 3:00:00 PM - RTT News

Pipeline Progress at Gilead - Analyst Blog
5/16/2013 2:29:32 PM - Zacks.com

Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert
5/13/2013 7:08:00 AM - Seeking Alpha

Osiris Loss In-Line with Expectations - Analyst Blog
5/8/2013 6:24:53 PM - Zacks.com

Athersys Has Some Promise, But Controversy And Doubt Remain
5/2/2013 4:06:00 PM - Seeking Alpha

Affymetrix Reports Disappointing 1Q - Analyst Blog
5/2/2013 8:49:01 AM - Zacks.com

Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog
5/1/2013 8:49:18 AM - Zacks.com

Stem Cells: Invest At Your Own Peril
5/1/2013 5:33:00 AM - Seeking Alpha

Double Setback for Gilead - Analyst Blog
4/30/2013 3:47:55 PM - Zacks.com

Geron Narrows Loss; Cuts Jobs - Analyst Blog
4/29/2013 10:03:23 AM - Zacks.com

Biogen's Earnings Surpass Expectations - Analyst Blog
4/25/2013 12:14:51 PM - Zacks.com

Sanofi's Vaccine Gets EU Approval - Analyst Blog
4/22/2013 12:09:57 PM - Zacks.com

An Industry Outlook With Analyst Vernon Bernardino
4/22/2013 5:30:00 AM - Seeking Alpha

Vertex CF Candidate Impresses - Analyst Blog
4/19/2013 3:40:01 PM - Zacks.com

Investing In The Stem Cell Sector: An Overview
4/17/2013 8:36:00 AM - Seeking Alpha

Osiris Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape
4/12/2013 12:06:01 PM - Zacks.com

Alkermes Announces Restructuring Plan - Analyst Blog
4/11/2013 5:06:42 PM - Zacks.com

Affymetrix to Disappoint in 1Q - Analyst Blog
4/10/2013 9:10:00 AM - Zacks.com

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
4/10/2013 4:00:00 AM - Seeking Alpha

Patients Dosed in Arena Study - Analyst Blog
4/9/2013 6:09:14 PM - Zacks.com

Sanofi Unveils Bond Issue Pricing - Analyst Blog
4/9/2013 4:08:12 PM - Zacks.com

ISIS Initiates ISIS-APOA Study - Analyst Blog
4/8/2013 6:09:14 PM - Zacks.com

Glaxo Eyes Benlysta Label Expansion - Analyst Blog
4/5/2013 3:09:05 PM - Zacks.com